SUMMARY Free fatty acid concentrations in plasma measured after in vivo heparinisation are often overestimated because of ex vivo lipolysis of variable degrees. A new method has been developed using immediate extraction of blood which obviates this and shows that the true rise in plasma free fatty acid concentration after heparin in ambulant ward patients and in patients with acute myocardial infarction is less than previously reported. The small rise in plasma free fatty acid concentration after heparin is unlikely to have adverse metabolic effects in most patients during acute myocardial infarction.
In addition to its anticoagulant action heparin has the effect of releasing several lipolytic enzymes into the circulation. I These act on circulating triglycerides and phospholipids to release free fatty acids and result in a raised level of plasma free fatty acid concentration. This may have an adverse effect on patients with acute myocardial infarction, as an association has been shown between raised plasma free fatty acid concentrations, serious ventricular arrhythmias, and poor prognosis.2-4 Increments in plasma free fatty acid concentration after heparin in man have been reported as varying between 750 and 1100ll moIl.5 6 Recorded values may be overestimated, however, in view of continuing ex vivo lipolysis before extraction.
The extent of this problem has been assessed by developing a technique of free fatty acid analysis after immediate whole blood extraction to elinbinate ex vivo lipolysis, and determining the true heparin-induced rise in plasma free fatty acid concentration in ambulant ward patients and in patients after acute myocardial infarction. Data are compared with those obtained by plasma extraction techniques.
Methods
The time course of plasma free fatty acid concentrations after the intravenous administration of heparin 12 500 international units (IU) was examined in three groups of patients. The first group (randomly selected general ward patients) consisted of nine men and one woman, aged 42 to 63 years. Their weights were between 49 and 99 kg. The patients were studied after overnight fasting. All except one were ambulant and one had known ischaemic heart disease.
The second (n=10) and third (n=10) groups consisted of patients who had had an acute myocardial infarction, and were admitted to the coronary care unit of the Royal Infirmary, Edinburgh. There were 17 men and three women (aged 38 to 69 years). The diagnosis was considered established if the criteria recommended by the World Health Organisation were fulfilled. Patients with a history of bleeding disorders, those in cardiogenic shock (systolic blood pressure <90 mmHg), or those requiring pacing or antiarrhythmic treatment were excluded, as were those on beta blockers or antilipolytic agents.
In a pilot study the effect of intravenous heparin (10 000 IU) was examined on ex vivo lipolysis in eight ambulant ward patients at peak lipaemia approximately two hours after lunch.
Informed consent was obtained from all patients. The study was approved by the local ethical committee.
PROCEDURE
The same procedure was followed in each group of patients. After insertion of a cannula in the antecubital vein, blood samples were taken for estimation of plasma triglyceride and free fatty acid concentrations, both 5 minutes and immediately before administration of 12 500 IU heparin intravenously and for estimation of plasma free fatty acid concentrations at five, 10, 15, 30, 45, 60, and 90 minutes after administration of heparin.
Blood samples were processed for free fatty acid estimations in three ways: (1) from one aliquot of the blood sample free fatty acids were extracted immediately without centrifugation using a newly developed method (see laboratory methods); (2) from another aliquot free fatty acids were extracted immediately after separation of plasma and blood cells by a short centrifugation at room temperature, with a four minute delay; (3) another aliquot of the sample was processed using our standard laboratory free fatty acid procedure (20 minute delay).
LABORATORY PROCEDURES
Plasma free fatty acid concentrations were determined using a titrimetric method.7 To avoid lipolysis in blood samples taken from subjects given heparin, during blood cell separation and processing leading to artificially high plasma free fatty acid concentrations, a new method was developed.8 Free fatty acids were immediately extracted into n-heptane from a whole blood sample (0.75 ml), as described for plasma samples.7 Plasma and red cell membrane phospholipids were removed from a 2*0 ml aliquot of the extract by selective adsorption to 200 mg silicic acid.9 The phospholipid free extract was evaporated under a stream of nitrogen in a heating block set at 60C. The fatty acids were redissolved in 3 ml chloroform-n-heptane 8:7 (vol/vol) and converted into their 63Ni-salts'0 by addition of 200 ul triethaolamine stabilised 63Ni solution in KBr. Final concentrations: triethanolamine 7-5% (vol/vol); KBr 40.5% (wt/vol); Ni (NO3)2 0 5 mmol/l; 63Ni specific activity (NBS 1, Amersham International) 4 mCi/mmol. After vigorous mixing for 15 to 20 seconds, followed by a short centrifugation (5 minutes at 1500 g) to separate the water and chloroform-heptane phases, the radioactive Ni-fatty acid salts in 1 ml of the upper chloroform-heptane phases were analysed by liquid scintillation counting using 9 ml liquid scintillant (NE 260, New England Nuclear). The method was calibrated using 99+% pure palmitic acid standards (British Drug House, Poole) dissolved in heptane, and taken through the extraction procedure.
The concentrations of fatty acids in blood extracts were expressed in terms of plasma concentrations, using a factor based on the packed cell volume, determined in quadruplicate using a Hawksley micro-haematocrit centrifuge.
The extraction of albumin-bound 3H-palmitate added to eight different human blood samples was on average 100-0+1 7% (mean+SEM). More than 94% of pure lecithin (2.75 mg/ml in heptane) was selectively absorbed to silicic acid. Blood lactate concentrations of less than 3-2 mmolI do not interfere; interferences by higher concentration were not examined.
The precision of the method was assessed by repeatedly (10 times) analysing a palmitic acid standard (400 ,umol/l) on two occasions. The coefficients of variations were 6 and 8-5%, respectively.
No statistically significant differences were found when results of the whole blood method were compared with the standard plasma free fatty acid titrimetric procedure in non-heparinised subjects, both when plasma free fatty acid concentrations are raised (Fig. 3) or within normal range ( Fig. 2 and 4) , p>0-05 paired t test.
Plasma triglycerides were determined in extracts (0.5 ml), prepared immediately after collection, by an automated fluorimetric method.1' Appropriate corrections for interference by free glycerol were made. The coefficient of variation of the method was 2%.
In patients with acute myocardial infarction, the vectorcardiogram was monitored in order to assess changes in ST segments as described previously. '2 Results are expressed as mean+SEM. The effect of heparin on plasma free fatty acid concentrations and differences between results obtained with the three free fatty acid methods were analysed using a paired Student's t test. P>0.05 was considered statistically nonsignificant.
Results

EX VIVO LIPOLYSIS AFTER HEPARIN ADMINISTRATION
Ex vivo lipolysis indicated by a rise in plasma free fatty acid concentrations was observed in blood samples obtained 15 minutes after the administration of 10 000 IU heparin to eight ambulant ward patients at peak lipaemia approximately two hours after lunch. Plasma triglyceride concentrations before administration of heparin ranged from 1.3 to 4.4; mean+SD: 3 1 ± 1.0 mmolI. When blood samples were incubated at room temperature plasma free fatty acid concentrations rose at a rate of approximately 30 ,umol/l per min (Fig. 1) . Cooling of blood did not prevent the increase in plasma free fatty acid concentration completely and in particular the initial rise was not abolished. EFFECT 4 The effect ofheparin (12500 IU intravenously) onplasmafreefatty acid concentrations in 10 patients with acute myocardial infarction (between 16 and 22 hours after onset ofsymptoms). Note mean plasmafreefatty acid concentrations before heparin are lower than in patients with acute nyocardial infarction studied earlier (Fig. 3) . Symbols as in Fig. 2 . group.bmj.com on June 24, 2017 -Published by http://heart.bmj.com/ Downloaded from mately 45 minutes later (Fig. 2) .
Plasma free fatty acid concentrations determined by both whole blood and rapid plasma extraction (four minutes delay) before administration of heparin were not significantly different. After administration, titrimetrically measured levels of heparin were consistently higher than those measured by the whole blood extraction method. Differences in free fatty acid levels recorded between the two methods were significant at all sampling periods after heparin (paired t test, O.O1<p<0.05).
When the extraction of plasma samples was delayed by 20 minutes, plasma free fatty acid concentrations were even higher. The increase in plasma free fatty acid concentrations 15 minutes after heparin over the pre-heparin value was then 693 pumol/l. This represents a 260% overestimation of plasma free fatty acid concentrations, when allowance is made for the "true" in vivo increase in the concentrations of plasma free fatty acids of 191 ,umol/l (Fig. 2) . This overestimation was closely related to the initial plasma triglyceride concentrations (r=0.82, n=8, p<0-01).
EFFECT OF HEPARIN ON IN VIVO PLASMA FREE FATTY ACID CONCENTRATIONS DURING ACUTE MYOCARDIAL INFARCTION
Plasma free fatty acid concentrations were raised in all patients admitted to the coronary care unit within six and a half hours after onset of symptoms of acute myocardial infarction: 1232±91 ,umolI (upper normal limit is 900 AmoWl) (Fig. 3) .
Before administration of heparin plasma free fatty acid values determined by all three methods did not differ significantly. As was observed in general ward patients, plasma free fatty acid concentrations after heparin were overestimated with the standard titrimetric method. The new method on whole blood extracts showed a true increment of 334±73 ,umol/l.
In 10 patients the effect of giving heparin was examined (12 500 IU) when plasma free fatty acid concentrations had passed their peak. Plasma free fatty acid levels returned to within the normal range in all but three patients studied between 16 and 22 hours after onset of symptoms. After giving heparin plasma free fatty acid concentrations rose from 658+80 to 983 +94 ,umol/I within 10 minutes (Fig. 4) .
This increment was similar to that observed in patients with acute myocardial infarction studied early after the onset of symptoms. Titrimetric analysis overestimated plasma free fatty acid concentrations after heparin also in these patients (Fig. 4) .
In six patients with acute myocardial infarction to whom heparin was administered within six and a half hours after the onset of symptoms ST segment vector magnitude was monitored and showed a gradual decline with respect to time before the administration Riemersma, Logan, Russell, Smith, Simpson, Oliver of heparin. This trend was not altered during the course of a transient heparin-induced increase in plasma free fatty acid concentrations (Table) .
Discussion
This study shows that the generally accepted procedures for the estimation of plasma free fatty acid concentrations lead to serious overestimations in subjects given heparin, as a result of in vitro lipolysis. Unless precautions are taken to prevent lipolysis in blood specimens between withdrawal and extraction, artificially high levels are obtained. This observation applies to blood taken from patients with and without acute myocardial infarction, who had been given heparin. In view of the high in vitro lipolytic rate (4%/o/min at room temperature), it was decided to extract whole blood specimens without processing. This new method will be valuable for studies where accurate measurements of plasma free fatty acid concentrations are imperative. Using this method we have now shown that in convalescent patients and patients with acute myocardial infarction plasma free fatty acid levels remained well within the physiological range, though plasma free fatty acid concentrations rose after the administration of heparin. The larger rises previously reported5 6 were mostly the result of delay in denaturing lipolytic enzymes in collected blood samples; in one of these studies5 plasma triglyceride levels were not measured and it is possible that higher free fatty acid concentrations resulted from higher circulating triglyceride levels. Other studies showing higher plasma free fatty acid concentrations after administration of heparin to patients with coronary artery disease support the view that this error is common.'3 14 Assessment of "true" plasma free fatty acid concentrations is necessary for understanding the relative importance of the proposed detrimental and beneficial effects of heparin on the ischaemic myocardium. Raised plasma free fatty acid concentrations have been associated with the development of serious ventricular arrhythmias in patients with acute myocardial group.bmj.com on June 24, 2017 -Published by http://heart.bmj.com/ Downloaded from infarction. 4 An hypothesis was proposed that this effect of raised plasma free fatty acid concentrations might lead to serious ventricular arrhythmias as a result of increasing oxygen requirements in the presence of ischaemia or a detergent effect or relative impairment of myocardial glucose metabolism. 15 Raised plasma free fatty acid concentrations exert a negative inotropic effect on the hypoxic or ischaemic myocardium,'6 17 which could offset the increase in myocardial oxygen consumption caused by the metabolic effects of free fatty acids. The relatively small "true" rise in plasma free fatty acid concentrations may explain why in our study and in previous studies heparin did not exacerbate ST segment abnormalities'3 14 18 or increase myocardial oxygen consumption in patients with acute infarction. '4 19 Heparin may have a protective role in addition to that against venous thromboembolism,20 by reducing blood viscosity and pulmonary oedema.2' Recently, it has been claimed to be more effective than beta blockade on short term prognosis. 22 If used in orthodox doses, provided there is no hyperlipidaemia, the metabolic effects on the ischaemic myocardium should be small and it should be safe in most patients when given several hours after the onset of symptoms. Its safety during the most acute phase has yet to be examined formally. In addition, its safety in the presence of hyperlipidaemia must be investigated. 
